On April 19, 2024, with the smooth transfusion of a bag of hematopoietic stem cells into the patient's body in the transplantation laminar flow ward of Lu Daopei Hospital, the hematopoietic stem cell transplantation of Lu Daopei Medical Group exceeded 10,000 cases, which lasted 12 years (2012~2024), becoming the shortest medical institution in the industry, reaching 10,000 cases of hematopoietic stem cell transplantation.
This figure not only represents the outstanding achievements of Lu Daopei Medical Group in the field of hematopoietic stem cell transplantation, but also the rebirth of countless families of blood disease patients.
At 13 o'clock in the afternoon of April 22, Lu Daopei Medical Group held a symposium on "10,000 Cases of Accumulation, Unlimited Innovative Students" in the conference room on the basement floor of Yanda Lu Daopei Hospital, Professor Liu Kaiyan, Executive Director of Beijing Lu Daopei Blood Disease Hospital/Executive Vice President of Beijing Lu Daopei Blood Disease Research Institute, 9 directors of the transplantation department, 3 directors of the hematology department, 4 directors of the laboratory department and other department colleagues attended to witness this historical moment.
In 1964, Academician Lu Daopei successfully completed the first hematopoietic stem cell transplantation in Asia and the fourth in the world, opening the door to hematopoietic stem cell transplantation in China. Since then, with the progress of medical technology and the improvement of people's health awareness, especially since the beginning of the 21st century, the optimization and progress of hematopoietic stem cell transplantation technology, China's international position in the field of hematopoietic stem cell transplantation has become increasingly stable and prominent.
Pioneering the way from scratch
Founder Academician Lu Daopei
01
In 1964, the first hematopoietic stem cell transplant from an allogeneic allogic donor in Asia was successfully completed, and it was also the fourth hematopoietic stem cell transplant in the world, with a patient surviving for 60 years after surgery, one of the longest surviving patients after bone marrow transplantation in the world.
In 1981, the first haploidentical hematopoietic stem cell transplantation in China was successfully completed.
02
03
At the beginning of the 21st century, he led the creation of the GIAC program, a globally recognized method for controlling GVHD and other complications after transplantation, ushered in the era of haploidentical hematopoietic stem cell transplantation in China, and was instrumental in promoting the growth of allogeneic hematopoietic stem cell transplantation.
After retiring from the Institute of Hematology of Peking University, where he established and served as the first director, Academician Lu Daopei founded Lu Daopei Hospital because he witnessed that many patients could not receive timely treatment because they did not have beds.
Refractory relapsed patients on the verge of despair came to Lu Daopei Hospital from all over the country, expecting that this would be the end of their road to seek medical treatment, and Daopei Hospital did not disappoint them, with the original intention of "saving lives and helping the wounded" and the persistence of "seeking up and down", the team put every patient in their hearts, constantly innovated clinical diagnosis and treatment plans, challenged one after another "impossible", and re-ignited the fire of life, Lu Daopei Hospital is also known as "the last stop for patients with blood diseases".
The path of development from 1 to 10000
Follow the light of our predecessors and set sail
In 2012, Lu Daopei Medical Group was established, relying on the clinical experience accumulated by the Lu Daopei medical team for many years, the spirit of Daopei, the application of new sophisticated hardware facilities and the international medical environment, it has won a good reputation in the industry at home and abroad, as well as the recognition and trust of the majority of patients with blood diseases.
According to incomplete statistics, up to now, the successful transplantation cases of Lu Daopei's medical team include congenital single kidney patients, children aged 2 months, 4 months, 6 months, and 8 months, 69-year-old, 70-year-old, 71-year-old, and 73-year-old patients, patients with aplastic anemia and hemophilia, patients who have undergone liver transplantation and then hematopoietic stem cell transplantation, children with rare diseases with high-risk and refractory Langerhans cell histiocytosis (LCH), children with mucopolysaccharidosis, salvage transplantation under high tumor burden, There are high-risk transplants for congenital immunodeficiency diseases, purine nucleoside phosphorylase deficiency transplants, and congenital dyserythropoiesis anemia transplants.......
The treatment experience of each difficult case has been transformed into a "treasure", and the "miracles of life" behind the cases one after another also vividly demonstrate the efforts made by the new generation of Daopei people to climb the peak of medicine.
From the first case to the 10,000th case, Lu Daopei Medical Group has been on this road for 12 years
As a participant, founder and witness of the development of Lu Daopei Medical Group, Professor Liu Kaiyan, Dean Lu Peihua, 9 directors of the Department of Transplantation, 3 directors of the Department of General Hematology and 4 directors of the Department of Laboratory Medicine took the stage one by one, and reviewed with deep affection the journey of the same Daopei platform that is not afraid of hardships, forges ahead and achieves their ideals on the Dadaopei platform.
Liu Kaiyan
Executive Director of Beijing Lu Daopei Blood Disease Hospital
The 10,000 cases of hematopoietic stem cell transplantation are a historical moment worth remembering. As a private medical institution, it is rare to achieve such achievements in such a sophisticated and difficult technical field as hematology, especially hematopoietic stem cell transplantation. I would like to thank Academician Lu for laying a solid foundation, thank all Daopei colleagues for their unremitting efforts, thank you for the trust of the patients' families, and hope that Daopei colleagues will make persistent efforts to make more contributions to the cause of hematopoietic stem cell transplantation in China.
Lu Peihua
Executive Medical Director of Lu Daopei Hospital
After 12 years, Lu Daopei Hospital has exceeded 10,000 cases of hematopoietic stem cell transplantation, becoming the shortest medical institution in the industry, reaching 10,000 transplants. The 10,000 transplants not only represent the outstanding achievements of Lu Daopei Hospital in the field of hematopoietic stem cell transplantation, but also the rebirth of countless families of blood disease patients, which is the best gift to this hopeful spring.
Zhou Jiarui
Director of the Department of Hematopoietic Stem Cell Transplantation
10,000 cases of transplantation is not the end, it is a thick accumulation that we stand on the shoulders of Academician Lu Daopei and make on the Daopei platform, and it is a new starting point for Daopei people to continue to run forward.
Zhao Yanli
Director of the Department of Hematopoietic Stem Cell Transplantation
In the future, we will continue to uphold the people-oriented, patient-oriented service concept, committed to innovation and development, explore new technologies and methods, and bring more vitality to patients.
Lu Yue
Director of the Department of Hematopoietic Stem Cell Transplantation
In the future, we will continue to innovate and effectively integrate the latest treatments into the hematopoietic stem cell transplantation process, so as to unlock more difficult cases, so that more patients can get the hope of a new life, live up to every expectation, and achieve the next milestone breakthrough.
Cao Xingyu
Director of the Department of Hematopoietic Stem Cell Transplantation
Behind 10,000 transplants are 10,000 lives and 10,000 families, and this number also makes me feel that as transplant doctors, we will also persevere and do our best to save more lives.
Kumamin
Director of the Department of Hematopoietic Stem Cell Transplantation
10,000 transplants is like a long march, "a manifesto, a propaganda team, and a seeding machine." "10,000 cases is our medical team's collective declaration of saving lives, establishing a reputation among patients, sowing hope and giving them a new lease of life.
Zhang Jianping
Director of the Department of Hematopoietic Stem Cell Transplantation
10,000 transplants are exploration, precipitation, accumulation, and a beginning. We explore in the dark and fight for the chance of life for patients who are relapsed and refractory, and in the future, we will use our rich experience to create more miracles of life.
Liu Deyan
Director of the Department of Hematopoietic Stem Cell Transplantation
Thanks to Academician Lu for building a medical platform, choosing medicine is choosing dedication, and I hope that every Daopei person will always practice the spirit of Daopei, tap this treasure trove of data of 10,000 cases, and expand the updated field for future medical technology and serve more patients.
Wei Zhijie
Director of the Department of Hematopoietic Stem Cell Transplantation
We must slowly accumulate cases, expand the source of the disease, lead our team, do a good job of passing on the help, and wish Daopei a hundred years of evergreen.
He Hai
Representative Sun Ruijuan, director of the Department of Hematopoietic Stem Cell Transplantation
Behind the 10,000 transplants is the hard work and dedication of hospitals, medical teams, patients' families, etc., and 10,000 cases is just a starting point.
Zhang Xian
Director of the Department of General Hematology
The Department of General Hematology will do its best to create opportunities for patients in need of transplantation, and I hope that we will continue to follow Academician Lu to save the lives of more patients and bring hope to more patients.
Yang Junfang
Director of the Department of General Hematology
From 1 to 10,000, everyone behind this number has worked tirelessly and boldly made breakthroughs, and in the future, we will work hand in hand with the Department of Transplantation and Laboratory Medicine to continue to save thousands of patients.
Lu Fanyong
Director of the Department of General Hematology
Academician Lu said that hematopoietic stem cell transplantation is a systematic project, and now this system is improving day by day and running well, and I hope that everyone will work together to create greater achievements.
Liu Hongxing
Head of the Department of Pathology and Laboratory Medicine
10,000 transplants is not only the number of completed cases, but also the high survival rate behind the numbers is even more exciting. The Department of Clinical Laboratory will grow together with the Department of Transplantation, Hematology and other departments of the hospital to create more miracles.
Wang Hui
Director of the Flow Cytometry Unit, Department of Pathology and Laboratory Medicine
Although it is hard to find thousands of waters, the sand is blown away and the gold is reached. 10,000 transplants are the hope of 10,000 lives, the happiness of 10,000 families, and a shining milestone in our long history of blood diseases.
Wang Tong
Director of the Laboratory of Cellular and Molecular Cytogenetics, Department of Pathology and Laboratory Medicine
10,000 cases is just a starting point, I believe that in the near future, we will have more breakthroughs, 20,000 cases, 50,000 cases or even 100,000 cases, so that more patients can get the hope of a new life, which is not only our wish, but also our goal.
Lung-hsien
Director of the Department of Cell Morphology, Department of Pathology and Laboratory Medicine
In the past 12 years, we have gone through ups and downs, overcome obstacles and keep forging ahead, and finally ushered in the historical moment of breaking through 10,000 cases, which is a symbol of our pioneering and enterprising, a display of comprehensive strength, and an important symbol of moving towards and becoming a world-class leader.
Li Xueying
Director of the Nursing Department of Yanda Lu Daopei Hospital
The treatment and rehabilitation of 10,000 patients has been the result of the efforts of clinical nurses, and we will do our best to do better in the future.
Zhang Bolong
Director of the outpatient department of Yanda Lu Daopei Hospital
"10,000" is a very auspicious number, and the heavy number of 10,000 contains the hard work of medical staff, inspectors and all Daopei people, as well as the trust of patients and families. We will also ride the wind and waves to create a more brilliant and bright future.
At the symposium, a mother of a child expressed her gratitude to the Daopei team on behalf of the patient's family.
Patient Representative
On behalf of the patient's family, I would like to say thank you to all of you! Thank you for your professionalism, which allows us to rekindle our expectations and hopes for the future, thank you for your warmth, let us feel not alone along the way, and thank you for your strength, so that we can use a positive attitude to take the test given by fate as a gift.
Representatives of the patient's family presented flowers to Lu Daopei's medical team
In 2012, Lu Daopei Medical Group was established, and in the same year, Lu Daopei Hematology and Tumor Center was established in Yanda Health City, and in 2015, it was renamed Hebei Yanda Lu Daopei Hospital.
In 2017, Lu Daopei Medical Group carried out a series of innovative management measures, adjusted the organizational structure, implemented the rotation system of transplant center directors, and communicated and collaborated more closely with other departments/departments, paying more attention to the needs and experience of patients, laying a solid foundation for the long-term development of the hospital.
In the following ten years, Beijing Lu Daopei Hospital and Beijing Lu Daopei Blood Disease Hospital have been put into operation, and up to now, the hospitals of Lu Daopei Medical Group have 860 beds and 137 100-level laminar flow wards. The new hospital in Shanghai, which will open soon, has a total of 276 beds, including 24 100-level laminar flow wards and 7 clean intensive care beds. It is expected that in 2025, Hebei Yanda Lu Daopei Hospital will open 800 beds and have at least 70 transplant warehouses after moving to a new location.
In 2019, the number of hematopoietic stem cell transplantation cases exceeded 1,000 for the first time, reaching 1,081 cases (more than 70% of which were related haploidentical transplantation), becoming one of the largest allogeneic hematopoietic stem cell transplantation centers in the world, and continued to grow against the trend from 2020 to 2023, with 1,473 cases of hematopoietic stem cell transplantation completed in 2023.
The annual number of transplant cases has increased from more than 100 cases in 2012 to more than 1,000 cases in 2019, and then to April 19, 2024, Lu Daopei's medical team has created a historic number in just 12 years - the 10,000th hematopoietic stem cell transplant has been completed. Behind the figures, there is the imprint of the tenacious growth of Lu Daopei's medical tree, which is now majestic and flourishing. It is like a monument that has witnessed the passage of time and the rebirth of countless lives, and also symbolizes the unremitting exploration of hematopoietic stem cell transplantation by the medical team of Landing Daopei.
Twelve is a cycle that signifies the end of a journey and the beginning of a new chapter. We will also take the 10,000th transplant as a new starting point, continue to pursue excellence, innovation and development, bring hope and vitality to more patients, and make greater contributions to the cause of blood diseases in China.
审校:Cherry排版:Red执行:Cherry
This platform aims to deliver more medical information to healthcare professionals. The content published on this platform should not be used as a substitute for professional medical guidance in any way, nor should it be regarded as diagnosis and treatment advice. If such information is used for purposes other than understanding medical information, the platform does not assume relevant responsibilities. This platform does not mean that it agrees with its descriptions and views on the published content. If copyright issues are involved, please contact us, and we will deal with it as soon as possible.